AI-generated summary
The authors systematically reviewed randomized controlled trials of laser photobiomodulation for pain in trigeminal neuralgia, pooling nine studies with 387 patients. Eight of nine studies reported greater pain reduction with photobiomodulation than with controls, and a meta-analysis of five studies found a significant effect. The authors note high heterogeneity, incomplete protocol reporting, and limited long-term data.
- Participants
- 387
- Studies included
- 9
- Who or what was studied
- Patients diagnosed with trigeminal neuralgia; no studies in postherpetic neuralgia met inclusion criteria.
- Limits stated in the abstract
- Substantial heterogeneity (I² = 92%), inconsistent or incomplete photobiomodulation protocol reporting, and limited long-term outcome data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
This systematic literature review aimed to assess the effectiveness of laser photobiomodulation therapy (PBM) in reducing pain in patients with trigeminal neuralgia and postherpetic neuralgia. Randomized controlled clinical trials were identified through searches in the following databases: PubMed, Web of Science, LILACS, EMBASE, Scopus, and the Cochrane Library. No studies involving patients with postherpetic neuralgia met the inclusion criteria and were therefore excluded. Nine studies, comprising a total of 387 patients diagnosed with trigeminal neuralgia, were included. In seven of these studies, patients also received pharmacological treatment, which was initiated either prior to or concurrently with the PBM intervention. A sham laser was used as a control in six studies. PBM parameters varied widely and were often incompletely reported, limiting the ability to compare treatment protocols. Qualitative analysis showed that eight out of nine studies reported a significantly greater reduction in pain scores in the PBM groups compared to control groups. A low to moderate risk of bias was found in two-thirds of the studies. The meta-analysis, which included five studies, demonstrated a significant effect of PBM in reducing pain scores (MD − 2.17; 95% CI, − 3.30 to − 1.04; P = 0.0002), although high heterogeneity was observed (I² = 92%). PBM appears to be an effective adjuvant therapy for trigeminal neuralgia, with a favorable safety profile and potential to reduce medication dependency. Nevertheless, the results should be interpreted cautiously due to substantial heterogeneity, lack of PBM protocol standardization, and limited long-term outcome data.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Meta-analysis, Systematic review, Heterogeneity, Photobiomodulation therapy, Risk of bias, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.